The role of ABO blood groups in blood rheology of cardiovascular disorders.
D000017:ABO Blood-Group System; D058186:Acute Kidney Injury / Q000097:blood; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000494:pharmacology; D001161:Arteriosclerosis / Q000097:blood; D001777:Blood Coagulation / Q000187:drug effects; D001809:Blood Viscosity / Q000187:drug effects; D002318:Cardiovascular Diseases / Q000097:blood* / Q000209:etiology; D003920:Diabetes Mellitus / Q000097:blood; D005260:Female; D006801:Humans; D006973:Hypertension / Q000097:blood; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood; D011928:Raynaud Disease / Q000097:blood; D012212:Rheology; D013997:Time Factors; D014665:Vasodilator Agents / Q000494:pharmacology
D000017:ABO Blood-Group System; D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D014665:Vasodilator Agents